Join
Live feed
·
PRReleasevia Quantisnow
LianBio logo

LianBio Announces Positive Topline Results from Phase 3 EXPLORER-CN Trial Evaluating Mavacamten in Chinese Patients

ByQuantisnow·Wall Street's wire, on your screen.
LIAN· LianBio
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIAN (LianBio) and more on Quantisnow.